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Abstract
Small airway and vessels play a critical role in chronic airway and pulmonary vascular diseases, but
their pharmacology has not been well characterised. We have studied airway and vascular
responses in rat lung slices and separately in vitro using myography. In lung slices, under basal
conditions, acetylcholine contracted airways, but had no vascular effect. The thromboxane
mimetic, U46619 contracted both vessels and airways. In the presence of U46619, acetylcholine
dilated vessels, but further contracted airways, an effect that was blocked by the nitric oxide
synthase inhibitor L-NG-nitro-L-arginine or apamin plus charybdotoxin, which inhibit endothelial-
derived hyperpolarising factor. Airway responses in lung slices were unaffected by L-NGnitro-L-
arginine methyl ester, indomethacin or apamin plus charybdotoxin. By contrast, apamin plus
charybdotoxin contracted bronchi studied in isolation. Our observations are the first to identify
mechanisms of endothelium dependent dilations in precision cut lung slices and the potential for
transverse hormonal communication between airways and vessels.
Background
In mammals the lung is made up of conducting airways
that carry air to the alveoli, the gas-exchanging units of the
lung. The airways branch from the hilum towards the
periphery. From the trachea to the terminal airways the
diameter decreases but there is a gradual increase in cross-
sectional area, because of the increase in number of air-
ways [1]. In the adult lung the pulmonary arteries run
alongside the airways, branching with them and decreas-
ing in diameter. They supply blood to the capillary area
closely matching that of the alveolar surface area. The pul-
monary veins drain the capillary bed and though they do
not run alongside the airways they have an equivalent
number of branches to the arteries. The close relationship
of the blood vessels and the airways is found throughout
the lung. However our understanding how they function
in parallel in situ is incomplete.
Acetylcholine dilates blood vessels [2] via activation of the
endothelium and the subsequent release of NO, prostacy-
clin and endothelial-derived hyperpolarizing factor
(EDHF), [3]. Acetylcholine constricts airways through
activation of muscarinic receptors on airway smooth mus-
cle cells [4]. However, it has been suggested that a bron-
chodilator is released by the epithelium and that this
'factor' could be NO [5]. Tonic responses of airways or
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pulmonary vessels are general studied separately, in isola-
tion using organ baths. In addition, some groups have
investigated tonic responses in airways [6-9]) or pulmo-
nary vessels [10,11]in situ in whole lung slices using ago-
nists. Methods applied to study airway and vascular
responses in the whole lung slices rely on the infusion of
a scaffold material such as agarose to facilitate the efficient
sectioning of the tissue. Functional endothelial-depend-
ent responses have been demonstrated in arteries and
veins of guinea-pig lung slices, although comparisons
with airway responses have not been made [12]. There are
no studies in which responses in airways and vessels have
been monitored simultaneously and where the role of
endogenous dilator hormones (e.g. NO) released by
either vascular endothelium, or airway epithelium, in
responses have been addressed. In the current study we
have measured the contractile and relaxant responses of
airways and vessels in situ in whole lung slices using video
microscopy [13]. Acetylcholine was added to the tissue in
the presence and absence of a constrictor agent. The
respective roles of NO, prostacyclin or EDHF in airway or
vascular responses were addressed by pharmacological
inhibitors. Finally, in each case, we have compared
responses of vessels and airways in whole lung slices with
those obtained using isolated structures in in vitro using
wire myographs.
2. Materials and methods
2.1. Preparation of lung slices
Lungs were taken from 6–8 week-old (230–270 g) female
Wistar rats and lung slices prepared as previously
described [13]. All the animals used in this project were
maintained and killed in accordance with The European
Community guidelines for the use of experimental ani-
mals.
The animals were killed by lethal exposure to CO2, trachea
was cannulated and the animals were exsanguinated by
cutting the vena cava inferior. A small vertical cut into the
diaphragm was made to collapse the lungs, followed by
immediate instillation of 15 ml of 2% agarose (low melt-
ing point agarose) solution into the airways. After the aga-
rose had cooled to 4°C, tissue cores were prepared by
advancing a rotating, sharpened metal tube (diameter 8
mm) longitudinally. From these cores, tissue slices (250
μm) were prepared using a Krumdieck tissue slicer (Ala-
bama Research and Development, Munford, AL, USA).
These slices were examined with an inverted microscope
and those that contained at least one cross section of a ves-
sel or an airway were placed in a 12 wells plate containing
1 ml of Dulbecco's modified Eagle's Medium (DMEM)
supplemented with 100 units.ml-1 penicillin, 0.1 mg.ml-1
streptomycin, 4 mM L-glutamine and 2.5 μg.ml-1 ampho-
tericin B and incubated overnight on a roller system
housed in a humidified incubator (37°C, 5% CO2-95%
air). Medium was changed every 45 minutes for the first 3
hours. Sections of lung containing 2/3rd order airways and
vessels were taken in order to parallel the structures stud-
ied in isolation using the myographs (see below).
2.2. Image acquisition
Incubation and observation of slices was carried on an
incubator chamber (PCLS-Bath Type 847, Hugo Sachs ele-
ktronik, Harvard Apparatus GmgH) containing 0.4 ml
complete DMEM placed on the stage of a microscope
(Nikon SMZ-U) and warmed to 37°C.
Arteries and airways were identified and imaged with a
video camera (Image Associates, UK). To distinguish arter-
ies from veins, we used criteria similar to those described
previously [11]: 1) The arteries usually accompanied air-
ways, whereas veins where at a distance from them, and 2)
arterial walls had a thick media and their inner lining was
slightly wrinkled, whereas veins were thinner and wrin-
kles were inconspicuous.
2.3. Experimental design
After preincubation for 5 minutes with 0.5 ml of DMEM,
the first image was acquired ("baseline image"). Then, the
liquid was removed and fresh medium added containing
acetylcholine (10-5 M). The slice was imaged every 20 sec-
onds for 6 minutes followed by a wash step which led to
a return to baseline. Then airways and vessels were pre-
contracted with the thromboxane analogue 9,11-Dide-
oxy-11α, 9α-epoxymethanoprostaglandin F2α (U46619,
10-7 M) and again images recorded every 20 seconds for 6
minutes. Acetylcholine (10-5 M) was then added for 5
min, with images recorded each 20 sec. In some experi-
ments acetylcholine was added to U46619 constricted air-
ways and vessels in the presence of the nitric oxide
synthase (NOS) inhibitor L-NGnitro-L-arginine methyl
ester (L-NAME; 10-3 M), the combined cyclo-oxygenase-1/
cyclo-oxygenase-2 inhibitor indomethacin (10-5 M) or the
combination of apamin and charybdotoxin (5 × 10-7 M
and 10-7 M) which together inhibit EDHF release (18). For
these experiments incubations were continued for 10
minutes with images recorded each 20 seconds as above.
2.4. Image analysis
The images were analysed using an image analysis pro-
gram (ZEISS KS 300 3.0). The luminal area was taken as
the area enclosed by the epithelial luminal border and was
quantified after setting the appropriate threshold value.
Baseline area was defined as 100%. The responses of arter-
ies and airways were calculated as a percentage of baseline
area using the equation: Response = residual area after
drug/baseline area X 100. Thus a 0% response indicated
complete luminal closure and 100% indicated no effect.Respiratory Research 2006, 7:111 http://respiratory-research.com/content/7/1/111
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2.5. Myography
In lungs from separate animals, second- to third-order
branch pulmonary arteries or bronchi were isolated from
the lungs of female Wistar rats and placed into modified
Krebs buffer (composition in 10-3 M): NaCl 119, KCl 4.7,
CaCl2, 2.5, MgSO4 1.17, NaHCO3 25, KH2PO4 1.18, EDTA
0.027 and glucose 5.5.
Pulmonary artery and bronchi were dissected our of fresh
lungs and cut into small segments and mounted in a four
channel Mulvanny-Halpern myograph under normalised
tension (7.5 kPa) [14]. The segments were first challenged
with high potassium solution (composition in 10-3 M:
KCl 123.7, CaCl2 2.5, MgSO4 1.17, NaHCO3 25, KH2PO4
1.18, EDTA 0.027 and glucose 5.5). Tissues were then
washed and incubated once again in Krebs buffer.
Concentration-response curves to either U46619 (10-9 to
10-6 M) or acetylcholine (10-8 to 10-5 M) were then carried
out and contractile responses in both airways or vessels
recorded and represented as active effective pressure (AEP;
Kpa; mN/mm2), calculated by the following equations:
ΔT = ΔF/2x segment length; AET = ΔT/vessel radius where
ΔT represent active wall tension and ΔF represents active
force response measured in mN. Airways or vessels were
then pre-contracted with an EC80  concentration of
U46619 and acetylcholine added (10-5 M). Responses
were allowed to plateau before individual inhibitors of
the NO, prostacyclin or EDRF pathways add, these were L-
NAME (10-3 M), indomethacin (10-5 M) or apamin (5 ×
10-7 M) plus charybdotoxin (10-7 M), [18] respectively.
Relaxant responses were calculated as a percentage of
U46619-induced tone. Data are given as the mean ± SEM.
2.7. Materials
All drugs were purchased from Sigma Gilligham, Dorset,
UK. Acetylcholine and indomethacin were freshly pre-
pared each day in aqueous and ethanol solutions, respec-
tively. U46619 was prepared in high concentration
"stock" solution dissolved in ethanol and was stored at -
80°C until used.
2.8. Statistics
Data was analysed using the appropriate tests and Graph-
Pad Software. T-tests, one-way analysis of variance or one-
sample T-test for normalised data was used as described in
the text or in the figure legends.
3. Results
3.1. Effects of acetylcholine and U46619 on airway and 
vascular responses in precision cut lung slices in situ
Acetylcholine contracted airways (10-5 M; -29.4 ± 7.3%)
but had no significant effect (103.7 ± 1.7%) on 'basal' pul-
monary vessel luminal area (n = 6). The thromboxane
mimetic U46619 (10-7 M) contracted both vessels (-37.8
± 0.7%) and airways (-39.5 ± 1.9%) (Figure 1 and 2). Fur-
thermore, in the presence of U46619, acetylcholine (10-5
M) dilated the vessel but further contracted the airway
(Figure 1 and 2). In separate experiments it was found that
L-NAME (10-3 M, % control; airway, 81.9 ± 7.4%: vessel
95.1 ± 6.6), indomethacin (10-5 M; airway, 100.8 ± 7.63:
vessel 92.4 ± 12.64) or apamin plus charybdotoxin (5 ×
10-7 M and 10-7 M; airway, 96.3 ± 7.71; vessel, 89.1 ± 5.2)
had no significant effect (using one-sample t-test; Graph-
Pad) on basal airway or vascular tone (n = 4). However, L-
NAME and the combination of apamin (5 × 10-7 M) plus
charybdotoxin (10-7 M) blocked the vasodilator effects of
acetylcholine in pre-constricted pulmonary vessels in lung
slices (Figure 2 and Figure 3). Neither L-NAME nor
apamin plus charybdotoxin affected contractile responses
Effects of U46619 (10-7 M) and acetylcholine (Ach; 10-5 M) on  internal luminal diameter of airway and vessels in whole pre- cision cut lung slices Figure 1
Effects of U46619 (10-7 M) and acetylcholine (Ach; 10-5 M) on 
internal luminal diameter of airway and vessels in whole pre-
cision cut lung slices. A; Tissue under control (basal condi-
tions) bathed in medium alone. B; Tissue after 6 min 
stimulation with U46619. C; Tissue after 5 min stimulation 
with U46619 and acetylcholine. The images are representa-
tive of those used in the pooled data shown in Figure 2.
BASAL
AIRWAY
VESSEL
U46619: 6 min
U46619+ ACh: 5 min
A
B
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to U46619 or acetylcholine in airways in lung slices (Fig-
ure 2 and Figure 3). Indomethacin (10-5 M) had no effect
on any responses in either airway or vessel structures in
the lung slice.
3.2. Effects of U46619 and ACh-induced responses in 
isolated airways and pulmonary arteries preparations in 
vitro
U46619 (10-9 to 10-6 M) induced concentration-depend-
ent contractions in either bronchi or pulmonary arteries in
vitro mounted in myographs (Emax 3.684 ± 0.877 mN
and 5.306 ± 0.476 mN respectively). For both tissues 10-7
M of U46619 represented an approximate EC80 concentra-
tion for contraction. Acetylcholine (10-8  to 10-6  M)
induced concentration dependent contractions of bron-
chi, but had no effect of pulmonary artery preparations
(0.355 ± 0.213 mN for 10-6 M acetylcholine). When pul-
monary vessels were pre-contracted with U46619 (10-7 M)
acetylcholine induced an immediate and profound and
stable vasodilator response (Figure 4). When acetylcho-
line was added to airway tissue, pre-contracted with
U46619, a further contraction was seen (Figure 5). When
L-NG-nitro-L-arginine methyl ester (10-3 M) was added to
the pre-constricted vessels, stimulated with acetylcholine,
it induced a rapid reversal of the dilator response (Figure
4). Similarly, when apamin (5 × 10-7 M), plus charyb-
Effects of U46619 (10-7 M) and acetylcholine (Ach; 10-5 M), in  the presence or absence of apamin (Ap, 5 × 10-7) plus  charybdotoxin (Ch, 10-7 M), (Ap+Ch), on internal luminal  diameter of airway and vessels in whole precision cut lung  slices Figure 3
Effects of U46619 (10-7 M) and acetylcholine (Ach; 10-5 M), in 
the presence or absence of apamin (Ap, 5 × 10-7) plus 
charybdotoxin (Ch, 10-7 M), (Ap+Ch), on internal luminal 
diameter of airway and vessels in whole precision cut lung 
slices. Panel A shows responses in pulmonary artery and 
panel B shows responses in bronchi. Measurements were 
made under basal conditions or after stimulation with 
U46619 (U4; 10-7 M) or acetylcholine (Ach; 10-5 M) or U4, 
plus Ach in the presence of Ap plus Ch. The results are the 
mean +/- the S.E.M for n = 3 experiments. A p-value of < 
0.05 was taken as statistically significant, calculated using 
ANOVA and denoted by *.
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Effects of U46619 (U4; 10-7 M) and acetylcholine (Ach; 10-5  M) in the presence or absence of L-NG-nitro-L-arginine  methyl ester (L-NAME) on internal luminal diameter of air- way and vessels in whole precision cut lung slices Figure 2
Effects of U46619 (U4; 10-7 M) and acetylcholine (Ach; 10-5 
M) in the presence or absence of L-NG-nitro-L-arginine 
methyl ester (L-NAME) on internal luminal diameter of air-
way and vessels in whole precision cut lung slices. Panel A 
shows responses in pulmonary artery and panel B shows 
responses in bronchi. Measurements were made under basal 
conditions or after stimulation with U46619 (U4; 10-7 M) or 
acetylcholine (Ach; 10-5 M) or U4, plus Ach in the presence 
of L-NAME. The results are the mean +/- the S.E.M. for n = 
4–6 experiments. A p-value of < 0.05 was taken as statisti-
cally significant, calculated using one sample t-test and 
denoted by *.
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dotoxin (10-7 M), was added in the same way the combi-
nation of drugs completely reversed acetylcholine
induced vasodilatation (Figure 4). Apamin plus charyb-
dotoxin had no effect on basal tone in vessels (0% of basal
tone). By contrast to results obtained in whole lung slices,
the combination of apamin plus charybdotoxin further
contracted airways stimulated with U46619 and acetyl-
choline (Figure 5).
4. Discussion
In the adult lung the pulmonary arteries run alongside the
airways, branching with them and decreasing in diameter.
Indeed, the airways and the vessels share an area of com-
mon interstitia which may allow transverse communica-
tion between the structures. It is therefore important to
study vascular and airway responses in parallel and in situ.
Previously this has been achieved using lung slices viewed
Characterisation of the effects of acetylcholine (ACh; 10-5 M)  in isolated pulmonary bronchi pre-constricted with U46619  (U4; 10-7 M) Figure 5
Characterisation of the effects of acetylcholine (ACh; 10-5 M) 
in isolated pulmonary bronchi pre-constricted with U46619 
(U4; 10-7 M). Panel A shows an original recording from a typ-
ical experiment. After equilibration, bronchi were contracted 
with U46619 (10-7 M), at plateau ACh was added and further 
contraction was observed. At plateau either L-NG-nitro-L-
arginine methyl ester (L-NAME; 10-3 M) or apamin (5 × 10-7 
M) plus charybdotoxin (10-7 M) was added, once a further 
plateau was achieved apamin plus charybdotoxin or L-NAME 
were added respectively. Panels B and C show pooled data 
from several experiments where L-NAME or apamin plus 
charybdotoxin were added individually. The data is expresses 
as the mean percentage of U46619-induced tone +/- the 
S.E.M and comprised of n = 4–5 experiments. A p-value of < 
0.05 was taken as statistically significant, calculated by t-test 
and denoted by *.
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Characterisation of the dilator effects of acetylcholine (ACh;  10-5 M) in isolated pulmonary artery Figure 4
Characterisation of the dilator effects of acetylcholine (ACh; 
10-5 M) in isolated pulmonary artery. Panel A shows an origi-
nal recording from a typical experiment. After equilibration, 
vessels were contracted with U46619 (10-7 M), at plateau 
ACh was added and immediate dilation occurred. At plateau 
either L-NG-nitro-L-arginine methyl ester (L-NAME; 10-3 M) 
or apamin (5 × 10-7 M) plus charybdotoxin (10-7 M) was 
added. Finally where L-NAME had been added, apamin plus 
charybdotoxin were added and visa versa. Panels B and C 
show pooled data from several experiments where L-NAME 
or apamin plus charybdotoxin were added respectively. The 
data is expressed as the mean percentage of induced tone +/
- the S.E.M and comprised of n = 4–6 experiments. A p-value 
of < 0.05 was taken as statistically significant, calculated by t-
test and denoted by *.
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using a microscope. However the relationship between
airway and vascular responses to endogenous mediators
released by the endothelium (or epithelium) has not pre-
viously been addressed.
Acetylcholine dilates blood vessels [2] via activation of the
endothelium and the subsequent release of NO, prostacy-
clin and EDHF [3]. Similarly, whilst acetylcholine con-
stricts airways via an action on the smooth muscle, [4] it
can also, as in vessels, activate the lining cells -namely the
epithelium, to release a bronchodilator substance [15,16].
The identity of epithelium-derived relaxing factor is
unknown [17], although NO has been implicated [5]. In
lung slices, we found that, under basal conditions, acetyl-
choline constricted airways, but had no effect on the adja-
cent pulmonary artery. For blood vessels to dilate, they
first need to be constricted. Thus, these observations sug-
gest that in lung slices either pulmonary vessels have no
intrinsic tone or that the endothelium is not functional.
When the thromboxane mimetic, U46619 was added to
the lung slices both the airway and the pulmonary artery
contracted. Under these conditions, the subsequent addi-
tion of acetylcholine produced significant dilator
responses in the artery, but not in the airway of lung slices.
These observations are consistent with what we found
using isolated pulmonary arteries and airways in vitro. In
lung slices, the dilator effects of acetylcholine on U46619
constriction tissue was blocked by L-NAME or by the com-
bination of apamin plus charybdotoxin. L-NAME is a
highly selective inhibitor of the NOS family. It inhibits all
forms of NOS (NOSI, NOSII and NOSIII). In blood ves-
sels, the release of NO induced by activation of the
endothelium by agents such as acetylcholine (as used in
this study) are always mediated by constitutive forms of
NOS (principally NOSIII). NO release by NOSII is inde-
pendent of calcium, and so would not by a stimulus such
as acetylcholine. We can therefore, safely conclude that in
lung slices the inhibitory effects we see with L-NAME are
via the selective inhibition of NOSIII in the endothelium.
Our results showing that the combination of apamin plus
charybdotoxin (inhibitors of small and intermediate
potassium dependent calcium channels respectively) also
inhibited acetylcholine induced vasodilatation in vessels
in the precision cut lung slice strongly suggest that EDHF
is also release by these structures. Whilst others have sug-
gested that pulmonary vessels in vitro release EDHF along
with NO to mediate endothelium dependent dilator
responses, we are the first to show this occurs in situ. This
is an important point because the role of EDHF in vascu-
lar responses is contentious and not always demonstrable
but instead is highly dependent upon the experimental
conditions applied. These observations show that the
mechanism of endothelium dependent dilation in lung
vessels in precision cut lung sections is mediated by NO
and EDHF. L-NAME had no effect on airway responses to
acetylcholine in the absence or presence of U46619. Sim-
ilarly apamin plus charybdotoxin did not influence air-
way responses in whole lung slices.
Results obtained in lung slices in situ were largely paral-
leled by responses of isolated pulmonary artery or bron-
chi in vitro. In isolated pulmonary artery preparations, the
vasodilator effects of acetylcholine were unaffected by
indomethacin, suggesting that prostacyclin release was
not involved in vasodilatation of rat pulmonary artery. In
contrast, in guinea-pig lung slices, indomethacin
increased dilator responses, possibly via the inhibition of
thromboxane release [11].
In isolated preparations acetylcholine had no relaxant
effect on U46619-constricted airways. Indeed, as was seen
in whole lung slices, acetylcholine further contracted
U46619 constricted airways. Interestingly we found that
by contrast to results in whole lung slices, the combina-
tion of apamin plus charybdotoxin further contracted iso-
lated bronchi, pre-contracted with U46619 and
acetylcholine. It is not clear why apamin plus charyb-
dotoxin should have constrictor effects (albeit small and
indirect) on isolated airway tissue, but not on airways in
situ, but may be a result of hormonal communication
between the structures, which would not be present when
tissues are separated.
In summary, our study is the first to demonstrate func-
tional endothelial responses in pulmonary vessels in
whole lung slices in situ. We describe a technique whereby
vascular and airway responses can be studied in parallel in
a physiologically superior technique. Finally we provide
data which suggests that some differences do exist
between responses (of airways) in lung slices versus in iso-
lation.
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